Yayın: Tumour lysis syndrome with acute renal failure during imatinib therapy
| dc.contributor.buuauthor | Ali, Rıdvan | |
| dc.contributor.buuauthor | Özkalemkaş, Fahir | |
| dc.contributor.buuauthor | Özkan, Atilla | |
| dc.contributor.buuauthor | Özçelik, Tülay | |
| dc.contributor.buuauthor | Özkocaman, Vildan | |
| dc.contributor.buuauthor | Akdağ, İbrahim | |
| dc.contributor.buuauthor | Ozan, Ülkü | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Nefroloji Ana Bilim Dalı | |
| dc.contributor.department | Hematoloji Ana Bilim Dalı | |
| dc.contributor.researcherid | AAG-8495-2021 | |
| dc.contributor.researcherid | AAH-1854-2021 | |
| dc.contributor.scopusid | 7201813027 | |
| dc.contributor.scopusid | 6601912387 | |
| dc.contributor.scopusid | 9250698600 | |
| dc.contributor.scopusid | 7005424333 | |
| dc.contributor.scopusid | 6603145040 | |
| dc.contributor.scopusid | 8342488100 | |
| dc.contributor.scopusid | 6507254632 | |
| dc.contributor.scopusid | 6602797853 | |
| dc.date.accessioned | 2022-09-16T12:18:50Z | |
| dc.date.available | 2022-09-16T12:18:50Z | |
| dc.date.issued | 2007-04 | |
| dc.identifier.citation | Ali, R. vd. (2007). "Tumour lysis syndrome with acute renal failure during imatinib therapy". Leukemia Research, 31(4), 573-574. | |
| dc.identifier.doi | 10.1016/j.leukres.2006.05.005 | |
| dc.identifier.endpage | 574 | |
| dc.identifier.issn | 0145-2126 | |
| dc.identifier.issn | 1873-5835 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pubmed | 16782190 | |
| dc.identifier.scopus | 2-s2.0-33846702520 | |
| dc.identifier.startpage | 573 | |
| dc.identifier.uri | https://doi.org/10.1016/j.leukres.2006.05.005 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0145212606001639 | |
| dc.identifier.uri | http://hdl.handle.net/11452/28793 | |
| dc.identifier.volume | 31 | |
| dc.identifier.wos | 000244826600025 | |
| dc.indexed.scopus | Scopus | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Pergamon-Elsevier Science | |
| dc.relation.journal | Leukemia Research | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Acute renal failure | |
| dc.subject | Cancer | |
| dc.subject | Imatinib | |
| dc.subject | Leukemia | |
| dc.subject | Tumour lysis syndrome | |
| dc.subject.emtree | Furosemide | |
| dc.subject.emtree | Allopurinol | |
| dc.subject.emtree | Asparaginase | |
| dc.subject.emtree | Calcium | |
| dc.subject.emtree | Creatinine | |
| dc.subject.emtree | Cyclophosphamide | |
| dc.subject.emtree | Daunorubicin | |
| dc.subject.emtree | Diuretic agent | |
| dc.subject.emtree | Imatinib | |
| dc.subject.emtree | Rare disease | |
| dc.subject.emtree | Hemoglobin | |
| dc.subject.emtree | Hydroxyurea | |
| dc.subject.emtree | Phosphorus | |
| dc.subject.emtree | Priority journal | |
| dc.subject.emtree | Tumor lysis syndrome | |
| dc.subject.emtree | Prednisolone | |
| dc.subject.emtree | Urea | |
| dc.subject.emtree | Uric acid | |
| dc.subject.emtree | Vincristine | |
| dc.subject.emtree | Acute kidney failure | |
| dc.subject.emtree | Potassium | |
| dc.subject.emtree | Adult | |
| dc.subject.emtree | Cancer combination chemotherapy | |
| dc.subject.emtree | Fatigue | |
| dc.subject.emtree | Case report | |
| dc.subject.emtree | Chronic myeloid leukemia | |
| dc.subject.emtree | Dehydration | |
| dc.subject.emtree | Drug effect | |
| dc.subject.emtree | Drug withdrawal | |
| dc.subject.emtree | Dyspnea | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Letter | |
| dc.subject.emtree | Male | |
| dc.subject.emtree | Pallor | |
| dc.subject.emtree | Petechia | |
| dc.subject.emtree | Purpura | |
| dc.subject.emtree | Retreatment | |
| dc.subject.emtree | Treatment outcome | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Antineoplastic agents | |
| dc.subject.mesh | Kidney neoplasms | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Leukemia, myeloid, chronic | |
| dc.subject.mesh | Kidney failure, acute | |
| dc.subject.mesh | Leukemia, myeloid, philadelphia-positive | |
| dc.subject.mesh | Piperazines | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Protein-tyrosine kinases | |
| dc.subject.mesh | Pyrimidines | |
| dc.subject.mesh | Tumor lysis syndrome | |
| dc.subject.scopus | Tumor Lysis Syndrome; Rasburicase; Hyperphosphatemia | |
| dc.subject.wos | Oncology | |
| dc.subject.wos | Hematology | |
| dc.title | Tumour lysis syndrome with acute renal failure during imatinib therapy | |
| dc.type | Article | |
| dc.wos.quartile | Q2 (Hematology) | |
| dc.wos.quartile | Q3 (Oncology) | |
| dc.wos.quartile | Q2 | |
| dc.wos.quartile | Q3 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Hematoloji Ana Bilim Dalı | |
| local.contributor.department | Tıp Fakültesi/Nefroloji Ana Bilim Dalı | |
| local.indexed.at | PubMed | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus |
Dosyalar
Lisanslı seri
1 - 1 / 1
